Edelris is greatly honoured to host Prof Laura Kiessling when she visits Lyon on her Ambassadors@INC “Chemical Biology Tour” on the 25th of April.
We are grateful to INC and the CNRS, which allows this brief, and remarkable visit of Prof Kiessling, at our premises.
We gladly invite you to join Edelris and Prof Kiessling for her conference (title to be announced shortly) at our site in Lyon on Tuesday 25/4 at 10:45 AM. Please register at reception@edelris.com (mandatory).
More news
About Edelris
Our DNA
Edelris has continuously been bringing creative solutions to clients and partners from drug discovery organizations for the past 17 years, with a clear focus on Hit generation and Hit-to-Lead optimization. Edelris has pioneered the value of 3D, natural productlike compound collections for HTS and FBLD (Keymical Collections™ and Fragments), and offers successful medicinal chemistry and synthesis of explorative chemical libraries, encoded and non-encoded. Further to this, Edelris differentiates itself with EDEN (Edelris Discovery ENgine) based upon a 2 million proprietary compound collection (Keymical Space™) and AS-MS technologies.
More info at www.edelris.com and LinkedIn.